1
|
B Payelle-BrogardS PellegriniBiochemical
monitoring of the early endocytic traffic of the type I interferon
receptorJ Interferon Cytokine
Res308998201010.1089/jir.2009.004420028207
|
2
|
TC YehS PellegriniThe Janus kinase family
of protein tyrosine kinases and their role in signalingCell Mol
Life Sci5515231534199910.1007/s00018005039210526570
|
3
|
GR StarkIM KerrBR WilliamsRH SilvermanRD
SchreiberHow cells respond to interferonsAnnu Rev
Biochem67227264199810.1146/annurev.biochem.67.1.2279759489
|
4
|
JS BonifacinoLM TraubSignals for sorting
of transmembrane proteins to endosomes and lysosomesAnnu Rev
Biochem72395447200310.1146/annurev.biochem.72.121801.16180012651740
|
5
|
KG KumarH BarriereCJ CarboneJ LiuG
SwaminathanP XuY LiDP BakerJ PengGL LukacsSY FuchsSite-specific
ubiquitination exposes a linear motif to promote interferon-alpha
receptor endocytosisJ Cell
Biol179935950200710.1083/jcb.20070603418056411
|
6
|
J LiuA PlotnikovA BanerjeeKG Suresh KumarJ
RagimbeauZ MarijanovicDP BakerS PellegriniSY
FuchsLigand-independent pathway that controls stability of
interferon alpha receptorBiochem Biophys Res
Commun367388393200810.1016/j.bbrc.2007.12.13718166147
|
7
|
J RagimbeauE DondiA AlcoverP EidG UzeS
PellegriniThe tyrosine kinase Tyk2 controls IFNAR1 cell surface
expressionEMBO J22537547200310.1093/emboj/cdg03812554654
|
8
|
KG KumarB VargheseA BanerjeeDP BakerSN
ConstantinescuS PellegriniSY FuchsBasal ubiquitin-independent
internalization of interferon alpha receptor is prevented by
Tyk2-mediated masking of a linear endocytic motifJ Biol
Chem2831856618572200810.1074/jbc.M800991200
|
9
|
DH NguyenL LudgateJ HuHepatitis B
virus-cell interactions and pathogenesisJ Cell
Physiol216289294200810.1002/jcp.2141618302164
|
10
|
G WarisKW HuhA SiddiquiMitochondrially
associated hepatitis B virus X protein constitutively activates
transcription factors STAT-3 and NF-kappa B via oxidative stressMol
Cell Biol2177217730200110.1128/MCB.21.22.7721-7730.2001
|
11
|
AS KekuleU LauerL WeissB LuberPH
HofschneiderHepatitis B virus transactivator HBx uses a tumour
promoter signalling
pathwayNature361742745199310.1038/361742a08441471
|
12
|
YH LeeY YunHBx protein of hepatitis B
virus activates Jak1-STAT signalingJ Biol
Chem2732551025515199810.1074/jbc.273.39.255109738022
|
13
|
YI LeeS Kang-ParkSI DoYI LeeThe hepatitis
B virus-X protein activates a phosphatidylinositol
3-kinase-dependent survival signaling cascadeJ Biol
Chem2761696916977200110.1074/jbc.M01126320011278872
|
14
|
P ChirilloM FalcoPL PuriM ArtiniC BalsanoM
LevreroG NatoliHepatitis B virus pX activates NF-kappa B-dependent
transcription through a Raf-independent pathwayJ
Virol7064164619968523586
|
15
|
H KimYH LeeJ WonY YunThrough induction of
juxtaposition and tyrosine kinase activity of Jak1, X-gene product
of hepatitis B virus stimulates Ras and the transcriptional
activation through AP-1, NF-kappaB, and SRE enhancersBiochem
Biophys Res Commun286886894200110.1006/bbrc.2001.549611527382
|
16
|
J ChenA SiddiquiHepatitis B virus X
protein stimulates the mitochondrial translocation of Raf-1 via
oxidative stressJ
Virol8167576760200710.1128/JVI.00172-0717428866
|
17
|
R SrisutteeSS KohEH ParkIR ChoHJ MinBH
JhunDY YuS ParkY Park doMO LeeUpregulation of Foxo4 mediated by
hepatitis B virus X protein confers resistance to oxidative
stress-induced cell deathInt J Mol Med28255260201121567078
|
18
|
EH ParkSS KohR SrisutteeIR ChoHJ MinBH
JhunYS LeeKL JangCH KimRN JohnstonYH ChungExpression of HBX, an
oncoprotein of hepatitis B virus, blocks reoviral oncolysis of
hepatocellular carcinoma cellsCancer Gene
Ther16453461200910.1038/cgt.2008.9519096445
|
19
|
IR ChoS JeongBH JhunWG AnB LeeYT KwakSH
LeeJU JungYH ChungActivation of non-canonical NF-kappaB pathway
mediated by STP-A11, an oncoprotein of Herpesvirus
saimiriVirology3593745200710.1016/j.virol.2006.09.00117028057
|
20
|
H IdeT NakagawaY TeradoY KamiyamaS MutoS
HorieTyk2 expression and its signaling enhances the invasiveness of
prostate cancer cellsBiochem Biophys Res
Commun369292296200810.1016/j.bbrc.2007.08.16017920038
|
21
|
PM Mulrooney-CousinsTI MichalakPersistent
occult hepatitis B virus infection: experimental findings and
clinical implicationsWorld J
Gastroenterol1356825686200710.3748/wjg.v13.i43.568217963292
|
22
|
SI GrivennikovFR GretenM KarinImmunity,
inflammation, and
cancerCell140883899201010.1016/j.cell.2010.01.025
|
23
|
MG BorrelloD Degl’InnocentiMA
PierottiInflammation and cancer: the oncogene-driven
connectionCancer
Lett267262270200810.1016/j.canlet.2008.03.06018502035
|
24
|
S LiS LabrecqueMC GauzziAR CuddihyAH WongS
PellegriniGJ MatlashewskiAE KoromilasThe human papilloma virus
(HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs
Jak-STAT activation by
interferon-alphaOncogene1857275737199910.1038/sj.onc.120296010523853
|
25
|
RJ LinCL LiaoE LinYL LinBlocking of the
alpha interferon-induced Jak-Stat signaling pathway by Japanese
encephalitis virus infectionJ
Virol7892859294200410.1128/JVI.78.17.9285-9294.200415308723
|
26
|
JT GuoJ HayashiC SeegerWest Nile virus
inhibits the signal transduction pathway of alpha interferonJ
Virol7913431350200510.1128/JVI.79.3.1343-1350.200515650160
|
27
|
D GarcinJB MarqL StrahleP le MercierD
KolakofskyAll four Sendai Virus C proteins bind Stat1, but only the
larger forms also induce its mono-ubiquitination and
degradationVirology295256265200210.1006/viro.2001.134212033784
|
28
|
B GotohT KomatsuK TakeuchiJ
YokooParamyxovirus strategies for evading the interferon
responseRev Med Virol12337357200210.1002/rmv.35712410527
|
29
|
P BarnardNA McMillanThe human
papillomavirus E7 oncoprotein abrogates signaling mediated by
interferon-alphaVirology259305313199910.1006/viro.1999.977110388655
|
30
|
DC LookWT RoswitAG FrickY Gris-AlevyDM
DickhausMJ WalterMJ HoltzmanDirect suppression of Stat1 function
during adenoviral
infectionImmunity9871880199810.1016/S1074-7613(00)80652-49881977
|
31
|
V ChristenF DuongC BernsmeierD SunM
NassalMH HeimInhibition of alpha interferon signaling by hepatitis
B virusJ Virol81159165200710.1128/JVI.01292-0617065208
|
32
|
SA BissonAL PageD GanemA Kaposi’s
sarcoma-associated herpesvirus protein that forms inhibitory
complexes with type I interferon receptor subunits, Jak and STAT
proteins, and blocks interferon-mediated signal transductionJ
Virol83505650662009
|
33
|
C WuQ GuanY WangZJ ZhaoGW ZhouSHP-1
suppresses cancer cell growth by promoting degradation of JAK
kinasesJ Cell Biochem9010261037200310.1002/jcb.1072714624462
|
34
|
J ChengD ZhangC ZhouWA
MarascoDownregulation of SHP1 and up-regulation of negative
regulators of JAK/STAT signaling in HTLV-1 transformed cell lines
and freshly transformed human peripheral blood CD4+
T-cellsLeuk Res287182200410.1016/S0145-2126(03)00158-914630083
|
35
|
C WuM SunL LiuGW ZhouThe function of the
protein tyrosine phosphatase SHP-1 in
cancerGene306112200310.1016/S0378-1119(03)00400-112657462
|
36
|
TW ChungYC LeeJH KoCH KimHepatitis B Virus
X protein modulates the expression of PTEN by inhibiting the
function of p53, a transcriptional activator in liver cellsCancer
Res6334533458200312839924
|
37
|
K AbdelmohsenR Pullmann JrA LalHH KimS
GalbanX YangJD BlethrowM WalkerJ ShubertDA GillespiePhosphorylation
of HuR by Chk2 regulates SIRT1 expressionMol
Cell25543557200710.1016/j.molcel.2007.01.01117317627
|
38
|
JK JungP AroraJS PaganoKL JangExpression
of DNA methyltransferase 1 is activated by hepatitis B virus X
protein via a regulatory circuit involving the p16INK4a-cyclin
D1-CDK 4/6-pRb-E2F1 pathwayCancer
Res6757715778200710.1158/0008-5472.CAN-07-052917575144
|